News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
806,833 Results
Type
Article (60212)
Company Profile (267)
Press Release (746337)
Multimedia
Podcasts (207)
Webinars (37)
Section
Business (248898)
Career Advice (3138)
Deals (38074)
Drug Delivery (220)
Drug Development (88360)
Employer Resources (185)
FDA (18012)
Job Trends (16097)
News (371759)
Policy (36007)
Tag
2025 Best Places to Work (2)
2026 Best Places to Work (2)
2027 BioCapital Elite (1)
2027 BioCapital Standard (5)
2027 BioMidwest Digital (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (2)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (11)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (8)
2027 Genetown Elite (4)
2027 Genetown Premier (1)
2027 Genetown Standard (12)
2027 Pharm Country Digital (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (11)
40 Under 40 (2)
Academia (3062)
Accelerated approval (74)
ADA (53)
Adcomms (44)
Allergies (229)
Alliances (55300)
ALS (284)
Alzheimer's disease (2113)
Antibody-drug conjugate (ADC) (753)
Approvals (18602)
Artificial intelligence (1021)
ASCO (349)
Autoimmune disease (494)
Automation (79)
Bankruptcy (391)
Belgium (35)
Best Places to Work (12350)
BIO (79)
Biologics (88)
BIOSECURE Act (23)
Biosimilars (298)
BioSpace Insights (183)
Biotechnology (170)
Bispecific (45)
Bladder cancer (242)
Brain cancer (99)
Breast cancer (956)
Cancer (7802)
Cardiovascular disease (659)
Career advice (2713)
Career pathing (65)
CAR-T (450)
CDC (76)
CDMO (214)
Celiac Disease (7)
Cell-line development (1)
Cell therapy (1199)
Cervical cancer (66)
Clinical research (78215)
Collaboration (2814)
Commercialization (56)
Company closure (9)
Compensation (1872)
Complete response letters (125)
COVID-19 (3050)
CRISPR (146)
CRO (3)
C-suite (1673)
Cystic fibrosis (182)
Data (10625)
Decentralized trials (4)
Denatured (59)
Depression (222)
Dermatology (189)
Diabetes (832)
Diagnostics (7771)
Digital health (80)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (494)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (380)
Earnings (94652)
Editorial (85)
Employer branding (22)
Employer resources (172)
ESMO (433)
Events (129424)
Executive appointments (1367)
Eye disease (16)
FDA (22984)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (5)
Friedreich's ataxia (28)
Frontotemporal dementia (42)
Funding (2301)
Gene editing (305)
Generative AI (90)
Gene therapy (942)
GLP-1 (1365)
Government (5348)
Grass and pollen (8)
Guidances (439)
Healthcare (21027)
Hematology (205)
HIV (118)
Huntington's disease (88)
Idiopathic pulmonary fibrosis (14)
IgA nephropathy (154)
Immunology and inflammation (423)
Immuno-oncology (159)
Indications (287)
Infectious disease (3498)
Inflammatory bowel disease (279)
Inflation Reduction Act (14)
Influenza (162)
Intellectual property (378)
Interviews (607)
IPO (17460)
IRA (56)
Job creations (4047)
Job search strategy (2168)
JPM (70)
Kidney cancer (30)
Kidney disease (168)
Labor market (128)
Layoffs (694)
Leadership (68)
Legal (8858)
Licensing (99)
Liver cancer (119)
Longevity (54)
Lung cancer (1083)
Lung diease (22)
Lymphoma (545)
Machine learning (76)
Management (70)
Manufacturing (1567)
Marketing (33)
MASH (249)
Medical affairs (5)
Medical device (15115)
Medtech (15427)
Mergers & acquisitions (22141)
Metabolic disorders (2091)
mRNA (328)
Multiple sclerosis (254)
Multispecific (6)
NASH (24)
Netherlands (31)
Neurodegenerative disease (617)
Neuropsychiatric disorders (150)
Neuroscience (4246)
Neurotech (4)
NextGen: Class of 2026 (7345)
Non-profit (5061)
Now hiring (51)
Obesity (986)
Opinion (401)
Ovarian cancer (296)
Pain (346)
Pancreatic cancer (447)
Parkinson's disease (480)
Partnered (48)
Patents (783)
Patient advocacy (5)
Patient recruitment (981)
Patient selection (97)
Peanut (76)
People (64932)
Peptides (29)
Pharmaceutical (59)
Pharmacy benefit managers (39)
Phase 1 (24240)
Phase 2 (34211)
Phase 3 (25742)
Pipeline (13754)
Policy (403)
Postmarket research (3012)
Preclinical (10280)
Press Release (74)
Prostate cancer (404)
Psychedelics (94)
Radioligand (3)
Radiopharmaceuticals (436)
Rare diseases (1564)
Real estate (6460)
Recruiting (80)
Regenerative medicine (28)
Regulatory (29245)
Reports (67)
Research institute (2750)
Resumes & cover letters (500)
Rett syndrome (59)
RNA editing (38)
RSV (104)
Schizophrenia (224)
Series A (402)
Series B (278)
Service/supplier (7)
Sickle cell disease (142)
Special edition (35)
Spinal muscular atrophy (194)
Sponsored (61)
Startups (4073)
State (2)
Stem cells (6)
Stomach cancer (24)
Substance use disorders (22)
Supply chain (164)
Switzerland (9)
Tariffs (107)
Tax incentives (1)
The Weekly (146)
Vaccines (1403)
Venture capital (167)
Weight loss (657)
Wet AMD (6)
Women's health (182)
Women in leadership (1)
Worklife (27)
Date
Last 7 days (838)
Last 30 days (2976)
Last 365 days (32879)
2026 (27640)
2025 (31973)
2024 (37002)
2023 (42007)
2022 (53370)
2021 (58118)
2020 (56971)
2019 (50313)
2018 (38340)
2017 (35171)
2016 (34918)
2015 (40743)
2014 (34479)
2013 (29848)
2012 (31993)
2011 (32321)
2010 (31005)
Location
Africa (1029)
Alabama (116)
Alaska (7)
Arizona (458)
Arkansas (17)
Asia (46006)
Australia (7847)
California (16587)
Canada (4597)
China (1982)
Colorado (732)
Connecticut (743)
Delaware (516)
Europe (104602)
Florida (2545)
Georgia (547)
Hawaii (5)
Idaho (69)
Illinois (1376)
India (147)
Indiana (763)
Iowa (35)
Japan (759)
Kansas (155)
Kentucky (68)
Louisiana (67)
Maine (85)
Maryland (1966)
Massachusetts (11990)
Michigan (448)
Minnesota (908)
Mississippi (8)
Missouri (185)
Montana (36)
Nebraska (31)
Nevada (192)
New Hampshire (92)
New Jersey (4345)
New Mexico (37)
New York (4347)
North Carolina (2165)
North Dakota (13)
Northern California (8498)
Ohio (519)
Oklahoma (32)
Oregon (52)
Pennsylvania (3192)
Puerto Rico (37)
Rhode Island (63)
South America (1396)
South Carolina (104)
South Dakota (2)
Southern California (6659)
Tennessee (277)
Texas (2754)
United States (58816)
Utah (507)
Vermont (2)
Virginia (421)
Washington D.C. (83)
Washington State (1333)
West Virginia (4)
Wisconsin (180)
Wyoming (6)
806,833 Results for "quintilesims quintiles inc merged with ims".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Curium Announces Definitive Agreement to Merge with Lantheus
August 3, 2026
·
21 min read
M&A
Supernus and Indivior merge to create CNS mega-company with 11 approved drugs
Supernus Pharmaceuticals and Indivior Pharmaceuticals are outlining a combined expected $2.2 billion in annual revenue, plus $125 million in cost savings that will include “natural redundancies.”
August 3, 2026
·
3 min read
·
Gabrielle Masson
Press Releases
Kincell Bio and Cellipont Bioservices Merge to Form Kincellis Advanced Therapies
September 17, 2026
·
3 min read
Press Releases
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
August 3, 2026
·
15 min read
Press Releases
Five Aponermin Studies Presented at the 23rd IMS Annual Meeting, Spanning Frail Newly Diagnosed and Hard-to-Treat Relapsed/Refractory Multiple Myeloma
Studies evaluate Aponermin combined with proteasome inhibitors, immunomodulatory drugs, cytotoxic agents, XPO-1 inhibitors, and BCL-2 inhibitors
September 29, 2026
·
1 min read
Press Releases
Immunome Announces IND Clearance for IM-1340, a Potential First-in-Class Antibody-Drug Conjugate for the Treatment of Solid Tumors
September 30, 2026
·
5 min read
Press Releases
AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026
September 17, 2026
·
4 min read
Press Releases
2026 IMS Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody IBI3003 (GPRC5D/BCMA/CD3) in Patients with Relapsed or Refractory Multiple Myeloma
September 29, 2026
·
10 min read
Press Releases
C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting
September 25, 2026
·
8 min read
Press Releases
Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-3050, an FAP-Targeted Radioligand Therapy, in Patients with FAP-Expressing Advanced Solid Tumors
July 20, 2026
·
4 min read
1 of 80,684
Next